American Society of Hematology

Annual Meeting Registration

Advance registration for the 56th ASH® Annual Meeting is now open.

Learn more

ASH Foundation 3K - 5K Run/Walk

December 7, 2014 - run or walk in the ASH Foundation 3K - 5K Run/Walk and help move hematology forward.

Learn more

ASH Academy

Now offering malignant and non-malignant hematology testing modules that provide both MOC and CME credit

Learn more

Protect Medical Research

Urge Congress to find a balanced approach to deficit reduction that does not involve further cuts to biomedical research.

Take action
Find a Hematologist

Find a Hematologist

Search a database of practicing hematologists in your area.

Learn more
Support Hematology

ASH Foundation

Help move hematology forward by supporting research, career development, and quality care and education programs.

Learn more
Join ASH

ASH Membership

Become part of a global network of more than 16,000 hematologists working to conquer blood diseases.

Learn more
  • ASH Pairs Hematologists from Developing and Developed Nations for Global Training Program

    The American Society of Hematology today announced the 20 hematologists and other medical professionals selected to participate in the 2014 ASH Visitor Training Program. This program provides talented hematologists, scientists, and laboratory staff from developing countries the opportunity to receive training on a specific area of hematology from an ASH member located anywhere in the world for up to 12 weeks. The goal of this program is to build hematology capacity in developing countries and ultimately improve the care of patients with blood diseases worldwide.

  • ASH Statement on Inaugural World Thrombosis Day

    The American Society of Hematology (ASH), the world’s largest professional society concerned with the causes and treatment of blood disorders, today joins the International Society on Thrombosis and Haemostasis (ISTH) and nearly 200 organizations worldwide to commemorate October 13, 2014, as the inaugural World Thrombosis Day, a day dedicated to raising awareness of potentially dangerous blood clots.

  • Statement from ASH President Linda J. Burns, MD, on Release of Sunshine Act Data

    Today the Centers for Medicare & Medicaid Services released a large set of data about the payments physicians and teaching hospitals received from pharmaceutical and medical device companies from August 1 to December 31, 2013.

  • Fellows and Junior Faculty Participate in 12th ASH Clinical Research Training Institute

    The American Society of Hematology (ASH) today announced the names of the 21 hematology trainees selected to participate in the 12th annual ASH Clinical Research Training Institute (CRTI). This education and mentorship program is designed to prepare current hematology and hematology/oncology fellows and junior faculty for careers in patient-oriented clinical research.

View all press releases
  • Potential Policy Fixes to Curb Medicare Part D Opioid Abuse

    The Medicare Payment Advisory Commission (MedPAC) is an advisory body to Congress that meets seven times a year. They offer recommendations to Congress on the various payment systems within Medicare, as well as monitor more focused topics of their choosing. During the most recent meeting on October 9, MedPAC analyzed data on opioid abuse for Medicare Part D enrollees.  Both the findings and potential policy implications could affect practicing hematologists who routinely prescribe opioids.

  • Ebola Alert

    The Department of Health and Human Services' Centers for Disease Control and Prevention (CDC) and Office of the Assistant Secretary for Preparedness and Response (ASPR) continues to respond to the current Ebola outbreak in West Africa. The CDC has summarized key messages about the outbreak and the response, and it will continue to update its resources as more information becomes available.

  • Sunshine Data Released – What’s Next?

    On September 30 at around 2PM, the Centers for Medicare and Medicaid Services (CMS) publicly released the data that it had been gathering from pharmaceutical and medical device companies that detail value transfers to physicians and medical schools.  ASH has been keeping members apprised of these developments since this provision was included in the Affordable Care Act.

  • Least Costly Alternatives for Drugs in the World of Hematology

    The Medicare Payment Advisory Commission (MedPAC) used its second session of the 2014-2015 cycle to take on an issue that could be very important for hematologists and access to drugs for their patients–the opportunity for Medicare to pay for drugs on a “least costly alternative” basis.  ASH continues to follow this issue as part of a commitment to ensure that policies are created that give patients efficient access to important drugs while maintaining clinician decision-making and incentives for continued innovation.

View all policy news
View all Hematologist articles